Privia Health Group, Inc.
PRVA· Nasdaq
Released Aug 3, 2023, before the open
10-Q filed Aug 3, 2023, 34 days after period end · 0001759655-23-000190
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $413.35M | $335.54M | $225.76M | $183.26M |
| Net Income | $7.27M | -$10.48M | -$172.53M | $5.28M |
| EPS Diluted |
Privia Health Group, Inc. · CIK 1759655 · Engraved from SEC EDGAR
| $0.06 |
| -$0.10 |
| -$1.68 |
| $0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.